Article
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.
Leukemia - 1 Jul 2026
Drewes Cosima, López Cristina, Okeke Nnamdi, Jebaraj Billy, Wiegreffe Christoph, Kraus Isabelle, Hillebrecht Sina, Awada Amani, Bens Susanne, Chteinberg Emil, Eichhorst Barbara, Datismann Sarah, Dyer Martin J S, Fischer Anja, Fischer Kirsten, Glaser Selina, Hallek Michael, Kretzmer Helene, Mottok Anja, Pfaff Dominick, Schnitzler Karoline, Meier-Kolthoff Jan P, Schlesner Matthias, Schneider Christof, Britsch Stefan, Ammerpohl Ole, Stilgenbauer Stephan, Tausch Eugen, Siebert Reiner
Abstract excerpt
Activation of oncogenes by hijacking immunoglobulin gene loci (IG) enhancers via chromosomal translocation is a common pathogenetic mechanism in B-cell malignancies, affecting 5-10% of chronic lymphocytic leukemia (CLL). The oncogenic partners in many of these cases remain unidentified. Therefore, we conducted a comprehensive analysis of 144 CLL samples with IGH-translocation excluding IGH::BCL2, IGH::CCND1,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
